Outcomes of transfemoral transcatheter aortic valve implantation (TAVI) and predictors of thirty-day major adverse cardiovascular events (MACE) and one-year mortality

Objective: TAVI is more frequently used to treat aortic stenosis with the mandate to have a low as possible rate of adverse events. We present our 30-day outcomes and one-year mortality and examine the factors associated with them. Methods: A prospective evaluation was performed of all patients who...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Christos Eftychiou, Nicolaos Eteocleous, Ioannis Zittis, Krikor Simamonian, Antonis Ioannou, Pantelitsa Loukaidou, Aliki Ntaka, Aris Hadjigregoriou, Vasilis Vasiliades, Maria Adamou, Eleni Constantinou, Panayiotis Avraamides
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2021-01-01
coleção:	Hellenic Journal of Cardiology
Assuntos:	Transcatheter Aortic Valve Implantation TAVI outcomes TAVI survival TAVI MACE
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S1109966620302013
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!